Additionally, we also observed a tendency of decrease in the Ki67-positive cancer cells in the dual treatment (50 ± 15.8%) compared with anti-VEGFR2 single treatment (69.8 ± 9.8%) (Suppl Table 1 and Suppl Fig. 3). The gene discussed is MKI67; the disease is cancer.